Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 61 - 80 of 125
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 May 2012, 11:11 am
According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible. [read post]
22 Mar 2012, 1:15 pm by Tom Lamb
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com)  Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. [read post]
14 Mar 2012, 10:42 am
Boehringer Ingelheim Pharmaceuticals Inc., et al.; U.S. [read post]
3 Mar 2012, 6:48 am by Max Kennerly, Esq.
(But not the two new huge drug cases: Boehringer Ingelheim, maker of Pradaxa, is in Connecticut, while Takeda, maker of Actos, is in Illinois.) [read post]
12 Jan 2012, 4:21 am
The IPKat has always been unhappy at the bit in Case C-348/04 Boehringer Ingelheim KG v Swingward Ltd: where the Court of Justice of the European Union said: "Where a parallel importer has failed to give prior notice to the trade mark proprietor concerning a repackaged pharmaceutical product, he infringes that proprietor’s rights on the occasion of any subsequent importation of that product, so long as he has not given the proprietor such notice. [read post]
5 Aug 2011, 6:21 am
Boehringer Ingelheim Pharmaceuticals, Inc., Pfizer, Inc., Pharmacia Corporation and Pharmacia & Upjohn, LLC, Nabil Gazal sued the maker of Mirapex for breach of warranty and failure to warn after he developed a serious gambling problem he ascribed to treatment with Mirapex. [read post]
28 Jul 2011, 11:19 am by Bexis
Boehringer Ingelheim Pharmaceuticals, No. 10-3129, slip op. (8th Cir. [read post]
12 Jul 2011, 6:59 am by randal shaheen
  The trouble started when Lilly entered a different agreement this year with Amylin competitor Boehringer Ingelheim to sell a rival diabetes drug:  BI’s Tradjenta. [read post]
9 Jun 2011, 12:43 pm by Jenna Greene
But Lilly recently struck a deal to promote a rival diabetes drug, Tradjenta, with Germany’s Boehringer Ingelheim using the same sales force. [read post]
4 May 2011, 10:00 am by Lucas A. Ferrara, Esq.
Tradjenta is marketed by Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conn., and Indianapolis-based Eli Lilly Co. [read post]
31 Jan 2011, 8:10 am by Stefanie Levine
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
31 Jan 2011, 8:10 am by Stefanie Levine
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
19 Dec 2010, 9:44 am
--Naik v Boehringer Ingelheim Pharm, Inc., 7thCir, November 22, 2010, No. 09-2960: Summary judgment upheld for employer after 53-year-old former pharmaceutical sales rep failed to show that termination based on falsification of call records, was pretext for age and national origin (Indian) discrimination in violation of the Age Discrimination in Employment Act (ADEA) and Title VII.The employer's legitimate non-discriminatory reason (LNDR) was pretty damning… [read post]
17 Dec 2010, 11:05 am by Bexis
Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. [read post]
9 Dec 2010, 3:53 am by Bob Kraft
" Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
9 Dec 2010, 2:49 am by Bob Kraft
” Specifically, “Boehringer Ingelheim GmbH’s Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]